KWRHIGH SIGNALFINANCIAL10-K

KWR experienced a dramatic financial deterioration with net income collapsing from $116.6M to a $2.5M loss while debt increased 23% to $869.8M.

The company's profitability has essentially evaporated with a 102% decline in net income and 73% drop in operating income, indicating severe operational challenges or one-time charges. The simultaneous 56% increase in interest expense combined with 23% higher debt levels suggests KWR is facing increasing financial leverage and borrowing costs at precisely the wrong time.

Comparing 2026-02-23 vs 2025-02-24View on EDGAR →
FINANCIAL ANALYSIS

KWR's financial performance deteriorated dramatically across all key metrics, with net income swinging from a healthy $116.6M profit to a $2.5M loss while operating income plummeted 73% and interest expenses surged 56%. The company increased debt by 23% to $869.8M and expanded inventory by 17%, suggesting either acquisition-related growth or potential demand weakness requiring higher working capital. Combined with declining operating cash flow (-33%) and reduced share buybacks, the overall picture signals a company under significant financial stress with deteriorating profitability and increasing leverage.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-102.1%
$116.6M-$2.5M

Net income declined 102.1% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-72.8%
$194.7M$53.0M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Interest Expense
P&L
+55.6%
$32.6M$50.7M

Interest expense surged 55.6% — significant debt increase or rising rates materially impacting earnings.

Capital Expenditure
Cash Flow
+33.6%
$41.8M$55.9M

Capital expenditure jumped 33.6% — major investment cycle underway; assess returns on deployment.

Operating Cash Flow
Cash Flow
-33.3%
$204.6M$136.5M

Operating cash flow fell 33.3% — earnings quality concerns; investigate working capital changes and non-cash items.

Total Debt
Balance Sheet
+23%
$707.2M$869.8M

Debt rose 23% — additional borrowing for investment or operations; monitor coverage ratios.

Inventory
Balance Sheet
+16.8%
$227.5M$265.8M

Inventory built 16.8% — monitor whether demand supports this build or if write-downs may follow.

Share Buybacks
Cash Flow
-15.7%
$49.2M$41.5M

Buyback activity reduced 15.7% — capital being redeployed elsewhere or cash conservation underway.

Total Liabilities
Balance Sheet
+13.1%
$1.3B$1.4B

Liabilities increased 13.1% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2026-02-23
PRIOR — 2025-02-24
ADDED
Other than of mineral oils, most of these raw material inputs are fourth to sixth generation derivatives of crude oil and natural gas, which are subject to volatile oil and gas prices and can cause significant variations in our raw materials costs.
Oleochemicals are impacted by their own unique supply and demand factors.
As experienced during 2025 and 2024, the Company s earnings have been and could continue to be affected by market changes in raw material prices.
Research and development expenses during the years ended December 31, 2025, 2024 and 2023 were $60.7 million, $57.3 million and $50.3 million, respectively.
Recent Acquisition Activity In April 2025, the Company acquired Dipsol Chemicals Co., Ltd.
+7 more — sign up free →
REMOVED
The following are the respective contributions to consolidated net sales of each of our principal product lines representing more than 10% of consolidated net sales for any of the past three years based on the Company s current product line segmentation: Major Product Line 2024 2023 2022 Metal removal fluids 22.4 % 23.6 % 22.9 % Rolling lubricants 20.5 % 19.5 % 20.8 % Hydraulic fluids 14.2 % 14.1 % 14.1 % Sales Revenue The Company s sales worldwide are made directly through its own employees and its Fluidcare TM programs, with the balance sold through distributors and agents.
As experienced during 2024 and 2023, the Company s earnings have been and could continue to be affected by market changes in raw material prices.
Research and development expenses during the years ended December 31, 2024, 2023 and 2022 were $57.3 million, $50.3 million and $46.0 million, respectively.
Recent Acquisition Activity Subsequent to the date of these financial statements, in February 2025, the Company acquired Chemical Solutions Innovations (Pty) Ltd.
( CSI ), for approximately $3.9 million, subject to routine and customary post-closing adjustments.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →